Global Equine Influenza Vaccine Market By Product Type (Liquid, Powder) And By End-Users/Application (Home, Pet Clinic) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

According to Apex Market Research the Equine Influenza Vaccine market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on Equine Influenza Vaccine market delivers detailed analysis covering major regional trends, market dynamics, and offer country-level market value of Equine Influenza Vaccine industry. Some of the major aspects considered during the course of research comprises definition of the product, classification of the product, industry structure, different participants in the Equine Influenza Vaccine ecosystem, etc. The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the Equine Influenza Vaccine market.

The following manufacturers are covered in this report:
  • Zoetis
  • Merck Animal Health
  • Boehringer Ingelheim Vetmedica

The report estimates on the Equine Influenza Vaccine market economy trend, market numbers (Mn/Bn USD) and CAGR from the 2020-2028, considering 2019 as the base year. A global Equine Influenza Vaccine market report consist of all leading industry players, Equine Influenza Vaccine business sections, company profile, revenue supply by Equine Influenza Vaccine industry sections, global Equine Influenza Vaccine market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result numerous economies around the world experienced severe economic downturn. Since early 2020, the Equine Influenza Vaccine market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the Equine Influenza Vaccine market in years 2020 and 2019 and moreover it offers forecast for the Covid-19 period from 2020 to 2028.The report provides COVID-19 impact on Equine Influenza Vaccine market, global analysis, different challenges or threats and opportunities for stakeholders involved in the Equine Influenza Vaccine market.

Report Opportunity: Global Equine Influenza Vaccine Market

This report delivers an analytical examination of the Equine Influenza Vaccine market summarized in broad sections such as
  1. Equine Influenza Vaccine Market Summary
  2. Key Commercial Growths in the Equine Influenza Vaccine Industry
  3. Market Dynamics Affecting the Equine Influenza Vaccine Industry
  4. Important Market Trends and Future Development Scenario of the Equine Influenza Vaccine Market
  5. Equine Influenza Vaccine Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of Equine Influenza Vaccine Industry
  7. Positioning of Main Market Players in the Equine Influenza Vaccine Industry
  8. Equine Influenza Vaccine Market Revenue and Forecast, by Application, 2018 - 2028
  9. Equine Influenza Vaccine Market Revenue and Forecast, by End-use, 2018 - 2028
  10. Equine Influenza Vaccine Market Revenue and Forecast, by Geography, 2018 - 2028
Equine Influenza Vaccine Market Segmentation:

The report provides detailed examination of the Equine Influenza Vaccine market on the basis of various segments such as type, application and end-use industry. The Equine Influenza Vaccine market is segmented as follows:

Equine Influenza Vaccine Market, by Type:
  • Liquid
  • Powder
Equine Influenza Vaccine Market, by Application:
  • Home
  • Pet Clinic
  • Other
Geographic Coverage

The report on the Equine Influenza Vaccine market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America Equine Influenza Vaccine Market Revenue and Forecast
  • U.S.
  • Canada
Europe Equine Influenza Vaccine Market Revenue and Forecast
  • UK
  • Germany
  • France
  • Rest of Europe
Asia Pacific Equine Influenza Vaccine Market Revenue and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Equine Influenza Vaccine Market Revenue and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Equine Influenza Vaccine Market Revenue and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Equine Influenza Vaccine Market Snapshot
          2.1.1. Global Equine Influenza Vaccine Market By Type,2019
               2.1.1.1.Liquid
               2.1.1.2.Powder
          2.1.2. Global Equine Influenza Vaccine Market By Application,2019
               2.1.2.1.Home
               2.1.2.2.Pet Clinic
               2.1.2.3.Other
          2.1.3. Global Equine Influenza Vaccine Market By End-use,2019
          2.1.4. Global Equine Influenza Vaccine Market By Geography,2019

3. Global Equine Influenza Vaccine Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Equine Influenza Vaccine Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Equine Influenza Vaccine Market Size (US$), By Type, 2018 – 2028

5. Global Equine Influenza Vaccine Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Equine Influenza Vaccine Market Size (US$), By Application, 2018 – 2028

6. Global Equine Influenza Vaccine Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Equine Influenza Vaccine Market Size (US$), By End-use, 2018 – 2028

7. Global Equine Influenza Vaccine Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Equine Influenza Vaccine Market Analysis, 2018 – 2028 
          7.2.1. North America Equine Influenza Vaccine Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Equine Influenza Vaccine Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Equine Influenza Vaccine Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Equine Influenza Vaccine Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Equine Influenza Vaccine Market Analysis, 2018 – 2028 
          7.3.1.  Europe Equine Influenza Vaccine Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Equine Influenza Vaccine Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Equine Influenza Vaccine Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Equine Influenza Vaccine Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Equine Influenza Vaccine Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Equine Influenza Vaccine Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Equine Influenza Vaccine Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Equine Influenza Vaccine Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Equine Influenza Vaccine Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Equine Influenza Vaccine Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Equine Influenza Vaccine Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Equine Influenza Vaccine Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Equine Influenza Vaccine Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Equine Influenza Vaccine Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Equine Influenza Vaccine Market Analysis, 2018 – 2028 
          7.6.1.  MEA Equine Influenza Vaccine Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Equine Influenza Vaccine Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Equine Influenza Vaccine Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Equine Influenza Vaccine Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Equine Influenza Vaccine Providers
        8.4.1 Zoetis
                8.1.1 Business Description
                8.1.2 Zoetis Geographic Operations
                8.1.3 Zoetis Financial Information
                8.1.4 Zoetis Product Positions/Portfolio
                8.1.5 Zoetis Key Developments
        8.4.2 Merck Animal Health
                8.2.1 Business Description
                8.2.2 Merck Animal Health Geographic Operations
                8.2.3 Merck Animal Health Financial Information
                8.2.4 Merck Animal Health Product Positions/Portfolio
                8.2.5 Merck Animal Health Key Developments
        8.4.3 Boehringer Ingelheim Vetmedica
                8.3.1 Business Description
                8.3.2 Boehringer Ingelheim Vetmedica Geographic Operations
                8.3.3 Boehringer Ingelheim Vetmedica Financial Information
                8.3.4 Boehringer Ingelheim Vetmedica Product Positions/Portfolio
                8.3.5 Boehringer Ingelheim Vetmedica Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Equine Influenza Vaccine Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Equine Influenza Vaccine Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Equine Influenza Vaccine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Equine Influenza Vaccine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Equine Influenza Vaccine Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Equine Influenza Vaccine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Equine Influenza Vaccine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Equine Influenza Vaccine Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Equine Influenza Vaccine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Equine Influenza Vaccine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Equine Influenza Vaccine Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Equine Influenza Vaccine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Equine Influenza Vaccine Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Equine Influenza Vaccine Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Equine Influenza Vaccine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Equine Influenza Vaccine Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Equine Influenza Vaccine: Market Segmentation 
FIG. 2 Global Equine Influenza Vaccine Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Equine Influenza Vaccine Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Equine Influenza Vaccine Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Equine Influenza Vaccine Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Equine Influenza Vaccine Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Equine Influenza Vaccine Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Equine Influenza Vaccine Providers, 2019
FIG. 11 Global Equine Influenza Vaccine Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Equine Influenza Vaccine Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Equine Influenza Vaccine Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Equine Influenza Vaccine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Equine Influenza Vaccine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Equine Influenza Vaccine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Equine Influenza Vaccine Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Equine Influenza Vaccine Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Equine Influenza Vaccine market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 
6588

1565

OUR CLIENT